1. Chazova, V. B., and Mychka, V. B. (2003. Metabolic syndrome, type 2 diabetes mellitus and arterial hypertension, Serdtse, 3, 32–38.
2. Bayzhanova, Zh. Zh., Ignatova, T. M., Severova, M. M., and Burnevich, E. Z. (2012. Hepatic steatosis and insulin resistance during chronic hepatitis C virus infection, Farmateka, 7, 26–29.
3. Von Frerichs, Fr. Th. (1884) Ueber den Diabetes, Berlin, 272.
4. Balabolkin, M. I., Kreminskaya, V. M., and Klebanova, E. M. (2005. A role of oxidative stress in pathogenesis of diabetic neuropathy and opportunity for its correction by alipoic acid-containing drugs, Probl. Endokrinol., 51, 22–33.
5. De Haan, J. B., Stefanovic, N., and Nikolic-Paterson, D. (2005. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy, Am. J. Physiol. Renal. Physiol., 289, 544–551.